New research led by scientists at La Jolla Institute for Immunology (LJI) reveals the workings of a human antibody called mAb 3A6, which may prove to be an important component for Ebola virus ...

To tackle the ongoing high burden of hepatitis C virus (HCV) infections among people who inject drugs (PWID), WHO has set a specific incidence target among PWID of no more than two new infections per ...